Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme

References

• Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14:1310–1316.
   PubMed Web of Science ®Google Scholar
• Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med 2005;172:1487–1490.
   PubMed Web of Science ®Google Scholar
• Yang S, Yuan W, Jin T. Formulating protein therapeutics into particulate forms. Expert Opin Drug Deliv 2009;6:1123–1133.
   PubMed Web of Science ®Google Scholar
• Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for peptide and protein delivery–liposomes versus lipid nanoparticles. Int J Nanomedicine 2007;2:595–607.
   PubMed Web of Science ®Google Scholar
• van der Walle CF, Sharma G, Ravi Kumar M. Current approaches to stabilising and analysing proteins during microencapsulation in PLGA. Expert Opin Drug Deliv 2009;6:177–186.
   PubMed Web of Science ®Google Scholar
• Jorgensen L, Moeller EH, van de Weert M, Nielsen HM, Frokjaer S. Preparing and evaluating delivery systems for proteins. Eur J Pharm Sci 2006;29:174–182.
   PubMed Web of Science ®Google Scholar
• Houchin ML, Topp EM. Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J Pharm Sci 2008;97:2395–2404.
   PubMed Web of Science ®Google Scholar
• Schwendeman SP. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit Rev Ther Drug Carrier Syst 2002;19:73–98.
   PubMed Web of Science ®Google Scholar
• van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res 2000;17:1159-1167.
   PubMed Web of Science ®Google Scholar
• Meyer JD, Manning MC. Hydrophobic ion pairing: altering the solubility properties of biomolecules. Pharm Res 1998;15:188–193.
   PubMed Web of Science ®Google Scholar
• Gaudana R, Khurana V, Parenky A, Mitra AK. Encapsulation of Protein-Polysaccharide HIP Complex in Polymeric Nanoparticles. J Drug Deliv 2011;2011:458128.
   PubMedGoogle Scholar
• Yang L, Cui F, Shi K, Cun D, Wang R. Design of high payload PLGA nanoparticles containing melittin/sodium dodecyl sulfate complex by the hydrophobic ion-pairing technique. Drug Dev Ind Pharm 2009;35:959–968.
   PubMed Web of Science ®Google Scholar
• Yuan H, Jiang SP, Du YZ, Miao J, Zhang XG, Hu FQ. Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles. Colloids Surf B Biointerfaces 2009;70:248–253.
   PubMed Web of Science ®Google Scholar
• Dai WG, Dong LC. Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing. Int J Pharm 2007;336:58–66.
   PubMed Web of Science ®Google Scholar
• Yoo HS, Choi HK, Park TG. Protein-fatty acid complex for enhanced loading and stability within biodegradable nanoparticles. J Pharm Sci 2001;90:194–201.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Itagaki H, Fukuda T, Tamura U, Sato Y, Suzuki Y. Hemoglobin denaturation caused by surfactants. Biol Pharm Bull 1995;18:540–543.
   PubMed Web of Science ®Google Scholar
• DeTrana C, Hurwitz RM. Painful purpura: an adverse effect to a thrombolysin. Arch Dermatol 1990;126:690–691.
   PubMedGoogle Scholar
• Dalwadi G, Sunderland B. An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles. Eur J Pharm Biopharm 2009;71:231–242.
   PubMed Web of Science ®Google Scholar
• Chen Y, Siddalingappa B, Chan PH, Benson HA. Development of a chitosan-based nanoparticle formulation for delivery of a hydrophilic hexapeptide, dalargin. Biopolymers 2008;90:663–670.
   PubMed Web of Science ®Google Scholar
• Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res 2010;27:544–575.
   PubMed Web of Science ®Google Scholar
• Gao G, Yan Y, Pispas S, Yao P. Sustained and extended release with structural and activity recovery of lysozyme from complexes with sodium (sulfamate carboxylate) isoprene/ethylene oxide block copolymer. Macromol Biosci 2010;10:139–146.
   PubMed Web of Science ®Google Scholar
• Stigter D, Dill KA. Charge effects on folded and unfolded proteins. Biochemistry 1990;29:1262–1271.
   PubMed Web of Science ®Google Scholar
• Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat Rev Drug Discov 2005;4:298–306.
   PubMed Web of Science ®Google Scholar
• McClements DJ. Non-covalent interactions between proteins and polysaccharides. Biotechnol Adv 2006;24:621–625.
   PubMed Web of Science ®Google Scholar
• Sacco D, Dellacherie E. Interaction of a macromolecular polyanion, dextran sulfate, with human hemoglobin. FEBS Lett 1986;199:254–258.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy R, Lumpkin JA, Sridhar R. Inactivation of lysozyme by sonication under conditions relevant to microencapsulation. Int J Pharm 2000;205:23–34.
   PubMed Web of Science ®Google Scholar
• Bilati U, Allémann E, Doelker E. Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech 2005;6:E594–E604.
   PubMed Web of Science ®Google Scholar
• Cai C, Bakowsky U, Rytting E, Schaper AK, Kissel T. Charged nanoparticles as protein delivery systems: a feasibility study using lysozyme as model protein. Eur J Pharm Biopharm 2008;69:31–42.
   PubMed Web of Science ®Google Scholar
• Amrutkar JR, Gattani SG. Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin. AAPS PharmSciTech 2009;10:670–677.
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W, Limpeanchob N. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles. Int J Pharm 2007;329:142–149.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Ferreira D. Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B Biointerfaces 2006;53:193–202.
   PubMed Web of Science ®Google Scholar
• Dalpiaz A, Vighi E, Pavan B, Leo E. Fabrication via a nonaqueous nanoprecipitation method, characterization and in vitro biological behavior of N(6)-cyclopentyladenosine-loaded nanoparticles. J Pharm Sci 2009;98:4272–4284.
   PubMed Web of Science ®Google Scholar